BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6292397)

  • 1. A comparison of the pharmacological properties of Clostridium botulinum type C1 and C2 toxins.
    Simpson LL
    J Pharmacol Exp Ther; 1982 Dec; 223(3):695-701. PubMed ID: 6292397
    [No Abstract]   [Full Text] [Related]  

  • 2. Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships.
    Simpson LL; Dasgupta BR
    J Pharmacol Exp Ther; 1983 Jan; 224(1):135-40. PubMed ID: 6294275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The interaction between toosedanin and botulinum toxin at the neuromuscular junction; an ultrastructural observation].
    Xiong CS
    Yao Xue Xue Bao; 1985 Jul; 20(7):495-9. PubMed ID: 4096241
    [No Abstract]   [Full Text] [Related]  

  • 4. [Paralysis of the anterior tibial muscle of the rat by the central action of botulinum toxin].
    Silva AJ
    Arch Farmacol Toxicol; 1979 Dec; 5(3):180-2. PubMed ID: 232648
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological studies on the subcellular site of action of botulinum toxin type A.
    Simpson LL
    J Pharmacol Exp Ther; 1978 Sep; 206(3):661-9. PubMed ID: 212546
    [No Abstract]   [Full Text] [Related]  

  • 6. On the mode of action of botulinum toxin.
    Leander S; Thesleff S
    Acta Physiol Scand; 1980 Feb; 108(2):195-6. PubMed ID: 6246722
    [No Abstract]   [Full Text] [Related]  

  • 7. The interaction between aminoquinolines and presynaptically acting neurotoxins.
    Simpson LL
    J Pharmacol Exp Ther; 1982 Jul; 222(1):43-8. PubMed ID: 6283072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The action of batulinum toxin at the neuromuscular junction.
    Sellin LC
    Med Biol; 1981 Feb; 59(1):11-20. PubMed ID: 6115105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of guanidine and germine on the neuromuscular block of botulism.
    Cherington M; Soyer A; Greenberg H
    Curr Ther Res Clin Exp; 1972 Feb; 14(2):91-4. PubMed ID: 4335307
    [No Abstract]   [Full Text] [Related]  

  • 10. [Role of axon flow in the mechanism of changes in the properties of skeletal muscle myocytes].
    Mikhaĭlov VV
    Fiziol Zh SSSR Im I M Sechenova; 1980 Nov; 66(11):1711-5. PubMed ID: 6160061
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro physiological studies on clostridial neurotoxins. Biological models and procedures for extracellular and intracellular application of toxins.
    Poulain B; Bader MF; Molgó J
    Methods Mol Biol; 2000; 145():259-86. PubMed ID: 10820727
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the mechanism of (+)-amphetamine enhancement of neuromuscular transmission: muscle contraction, electrophysiological and biochemical results.
    Snider RM; Gerald MC
    J Pharmacol Exp Ther; 1982 Apr; 221(1):14-21. PubMed ID: 6121051
    [No Abstract]   [Full Text] [Related]  

  • 13. Tetanus toxin blocks the neuromuscular transmission in vitro like botulinum A toxin.
    Habermann E; Dreyer F; Bigalke H
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Feb; 311(1):33-40. PubMed ID: 6245375
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacological properties of a new antidepolarizing curare-like compound, diadonium diiodide].
    Kharkevich DA
    Farmakol Toksikol; 1970; 33(5):531-6. PubMed ID: 4321817
    [No Abstract]   [Full Text] [Related]  

  • 15. Antagonism of botulinum toxin paralysis by low temperature.
    Lundh H
    Muscle Nerve; 1983 Jan; 6(1):56-60. PubMed ID: 6302501
    [No Abstract]   [Full Text] [Related]  

  • 16. Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes.
    Singer C; Weiner WJ
    Muscle Nerve; 1993 Jun; 16(6):677. PubMed ID: 8389003
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiac effects of botulinal toxin.
    Lamanna C; el-Hage AN; Vick JA
    Arch Int Pharmacodyn Ther; 1988; 293():69-83. PubMed ID: 3421785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships of leukocyte metabolism to Clostridium botulinum pathogenicity.
    Suzuki JB; Benedik A; Grecz N
    Res Commun Chem Pathol Pharmacol; 1971; 2(4):633-48. PubMed ID: 4945072
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of new 4-aminopyridine derivatives on neuromuscular transmission and on smooth muscle contractility.
    Berger SG; Waser PG; Hofmann A
    Arzneimittelforschung; 1989 Jul; 39(7):762-5. PubMed ID: 2551304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of botulinum neurotoxin types A and E at the rat neuromuscular junction.
    Sellin LC; Kauffman JA; Dasgupta BR
    Med Biol; 1983 Apr; 61(2):120-5. PubMed ID: 6308364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.